This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reed, G. L. Articles by Haber, E. Search for Related Content PubMed PubMed Citation Articles by Reed, G. L., 3d Articles by Haber, E.

Circulation, Vol 82, 164-168, Copyright © 1990 by American Heart Association

ARTICLES

Inhibition of clot-bound alpha 2-antiplasmin enhances in vivo thrombolysis

GL Reed 3d, GR Matsueda and E Haber
Massachusetts General Hospital, Cardiac unit, Boston 02114.

Recent experiments in vitro have shown that inhibition of human alpha 2- antiplasmin by a monoclonal antibody (MAb RWR) markedly enhances clot lysis by plasminogen activators. To extend these studies in vivo, we tested whether inhibition of clot or fibrin-bound alpha 2-antiplasmin by MAb RWR could enhance the lysis of a human clot by tissue-type plasminogen activator (t-PA) in a rabbit jugular vein thrombosis model. Compared with a saline placebo or a control antibody, MAb RWR significantly increased thrombolysis by endogenous plasminogen activator in rabbits to which no t-PA was administered (p less than 0.05). In rabbits that received t-PA, the combination of MAb RWR and t- PA caused significantly greater thrombolysis than equivalent doses of t- PA alone (p less than 0.05). However, compared with equipotent doses of t-PA alone, the combination of MAb RWR and t-PA did not increase the nonspecific consumption of fibrinogen. These experiments suggest that the combination of an alpha 2-antiplasmin inhibitor and a plasminogen activator could be a more potent thrombolytic strategy.

This article has been cited by other articles:

				C. A. Garofalo, S. E. Cabreriza, T. A. Quinn, A. D. Weinberg, B. F. Printz, D. T. Hsu, J. M. Quaegebeur, R. S. Mosca, and H. M. Spotnitz Ventricular Diastolic Stiffness Predicts Perioperative Morbidity and Duration of Pleural Effusions After the Fontan Operation Circulation, July 4, 2006; 114(1_suppl): I-56 - I-61. [Abstract] [Full Text] [PDF]

				G. S. Van Arsdell, B. W. McCrindle, K. D. Einarson, K.-J. Lee, E. Oag, C. A. Caldarone, and W. G. Williams Interventions associated with minimal Fontan mortality Ann. Thorac. Surg., August 1, 2000; 70(2): 568 - 574. [Abstract] [Full Text] [PDF]

				B. Airan, R. Sharma, S. K. Choudhary, S. R. Mohanty, A. Bhan, U. K. Chowdhari, R. Juneja, S. S. Kothari, A. Saxena, and P. Venugopal Univentricular repair: is routine fenestration justified? Ann. Thorac. Surg., June 1, 2000; 69(6): 1900 - 1906. [Abstract] [Full Text] [PDF]

				L. Lorand Sol Sherry Lecture in Thrombosis : Research on Clot Stabilization Provides Clues for Improving Thrombolytic Therapies Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 2 - 9. [Full Text] [PDF]

				K. N. Lee, W.-C. Tae, K. W. Jackson, S. H. Kwon, and P. A. McKee Characterization of Wild-Type and Mutant alpha 2-Antiplasmins: Fibrinolysis Enhancement by Reactive Site Mutant Blood, July 1, 1999; 94(1): 164 - 171. [Abstract] [Full Text] [PDF]

				G. L. Reed and A. K. Houng The Contribution of Activated Factor XIII to Fibrinolytic Resistance in Experimental Pulmonary Embolism Circulation, January 19, 1999; 99(2): 299 - 304. [Abstract] [Full Text] [PDF]

				M. Nagashima, Y. Imai, Y. Takanashi, S. Hoshino, K. Seo, M. Terada, and M. Aoki Ventricular Hypertrophy as a Risk Factor in Ventricular Septation for Double-Inlet Left Ventricle Ann. Thorac. Surg., September 1, 1997; 64(3): 730 - 734. [Abstract] [Full Text]

				K. Miyaji, M. Shimada, A. Sekiguchi, A. Ishizawa, and T. Isoda Usefulness of Pulsatile Bidirectional Cavopulmonary Shunt in High-Risk Fontan Patients Ann. Thorac. Surg., March 1, 1996; 61(3): 845 - 850. [Abstract] [Full Text]

				H. Ichikawa, T. Yagihara, H. Kishimoto, F. Isobe, F. Yamamoto, K. Nishigaki, O. Matsuki, and T. Fujita Extent of Aortopulmonary Collateral Blood Flow as a Risk Factor for Fontan Operations Ann. Thorac. Surg., February 1, 1995; 59(2): 433 - 437. [Abstract] [Full Text]